NOVO HOLDINGS A/S
CIK 1388325
13F filing for Q2 2026・No. 1,814
- Holdings
- US$1.72B
- Quarter change
- +US$488M
- Entries
- 25
- Net bought (estimate)
- +US$226.02M
The quarter change is the holdings' value against the quarter before, price moves included — not what was bought or sold; each institution's page estimates that.
Net bought (estimate)
Each stock's change in shares at the quarter-end price, added up: a new position counts as bought, one sold out as sold, shares held long only. Splits are compared split-adjusted; corporate actions under a new CUSIP are not estimated. An estimate from the filings, not actual trades.
- New 6
- Sold out 3
- Cut 8
- Added 2
- Corporate actions 0
- Unchanged 9
Largest holdings
25 stocks worth US$1.72B, options and bonds left out.
| Stock | This quarter | Shares | Value | Weight |
|---|---|---|---|---|
| EDGEWISE THERAPEUTICS INCCOM | Unchanged | 5,350,000 | US$217.37M | 12.62% |
| ASMLASML HOLDING N VN Y REGISTRY SHS | Unchanged | 94,946 | US$188.89M | 10.97% |
| COAGHEMAB THERAPEUTICS HLDGS INCCOM SHS | New | 4,180,550 | US$153.55M | 8.92% |
| BNBROOKFIELD CORPCL A LTD VT SH | Unchanged | 3,496,245 | US$149.53M | 8.68% |
| MAPLIGHT THERAPEUTICS INCCOM | Unchanged | 3,686,622 | US$132.13M | 7.67% |
| MIRUM PHARMACEUTICALS INCCOM | Cut | 1,125,000 | US$131.7M | 7.65% |
| AVLNAVALYN PHARMACEUTICALS INCCOM SHS | New | 3,883,289 | US$127.84M | 7.42% |
| CRMSALESFORCE INCCOM | Unchanged | 393,187 | US$61.6M | 3.58% |
| AVBPARRIVENT BIOPHARMA INCCOM | Cut | 1,500,000 | US$52.11M | 3.03% |
| ELVNENLIVEN THERAPEUTICS INCCOM | Cut | 1,000,000 | US$50.75M | 2.95% |
Sign in (free) to see its 25 largest holdings and its trades. Sign in
Filings
The quarter's original 13F filings (SEC).
- 13F-HRFiled August 14, 2026SEC ↗
13F covers long positions in US-listed securities only; the data is SEC's, filed within 45 days of the quarter's end.